GlassScriptPhysician profile
Shirley M Chan
NPI 1609830348
$2,472.11
in general payments reported to CMS, 2019-2025
26 companies · $416 in 2025
The $416 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $838 · 2020: $381 · 2021: $229 · 2022: $232 · 2023: $237 · 2024: $140 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $710.83 | 2019-2022 | |
| Therapeuticsmd, INC. | $328.44 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $158.13 | 2025 | Cobenfy |
| Exeltis, USA INC. | $155.31 | 2019-2025 | Slynd |
| Mayne Pharma Commercial LLC | $114.21 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $112.45 | 2023-2024 | Myfembree |
| Hologic Sales and Service, LLC | $103.20 | 2019-2024 | Thinprep 2000 Processor, Aptima, Affirm Prone Biopsy System |
| Duchesnay USA Incorporated | $87.06 | 2019 | |
| Amag Pharmaceuticals, INC. | $85.18 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $66.01 | 2019-2020 | |
| Sage Therapeutics, LLC | $54.58 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $54.58 | 2025 | Qelbree |
| Shield Therapeutics INC | $53.05 | 2023 | Accrufer |
| Exact Sciences Corporation | $52.56 | 2023 | Cologuard Collection Kit |
| Allergan, INC. | $46.96 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $37.38 | 2019-2022 | |
| Smith+Nephew, INC. | $35.85 | 2019 | |
| Myovant Sciences INC. | $35.16 | 2022 | |
| Roche Diagnostics Corporation | $30.46 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.20 | 2022 | |
| Pfizer INC. | $25.34 | 2025 | |
| Aspira Women'S Health INC | $22.48 | 2019 | |
| Organon LLC | $22.28 | 2024 | |
| Ascend Therapeutics US, LLC | $21.04 | 2021 | |
| Sanofi Pasteur INC. | $16.85 | 2025 | |
| Coopersurgical, INC. | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shirley Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.